UnitedHealth Group Incorporated (NYSE:UNH) finished Thursday with a subtraction of -$6.28 to close at $511.18, a downside of -1.21 percent. An average of 1,995,885 shares of common stock have been traded in the last five days. There was a fall of -$8.80 in the past week, and it reached a new high 37 times over the past 12 months. The last 20 days have seen an average of 2,366,826 shares traded, while the 50-day average volume stands at 2,371,230.
UNH stock has decreased by -3.42% in the last month. The company shares reached their 1-month lowest point of $506.10 on 09/14/22. With the stock rallying to its 52-week high on 04/14/22, shares of the company touched a low of $383.12 and a high of $553.29 in 52 weeks. It has reached a new high 17 times so far this year and achieved 3.05% or $10.08 in price. In spite of this, the price is down -7.61% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
28 days have passed since UnitedHealth Group Incorporated (UNH) last reported insider trading activity. ROOS THOMAS E, who is Chief Accounting Officer, most recently acquired $465 shares at $542.37 per share on Aug 26. In this transaction, the insider spent $252,201. Pres. & COO, UHG & CEO, UHC, McMahon Dirk C, disposed of 14,715 shares at a price of $543.32 on Aug 18. The insider now owns more than $7,994,939 worth of shares. Prior to that, EVP Chief Financial Officer REX JOHN F went on to Sale 13,183 shares at $541.53 each on Jul 29. An amount of $7,138,990 was transacted.
UnitedHealth Group Incorporated (UNH) has a trailing price-to-earnings (P/E) ratio of 27.03. The stock’s beta is 0.77. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.58, the price-to-book (PB) ratio at 6.66, and the price-to-cash flow ratio at 32.80.
The company has a payout ratio of 30.90%. The company’s most recent quarterly dividend payment was $1.65 a share, without any change from last year. Its latest increase dividend $0.20 reported on Thursday June 9 2022.
Further, the company has a long term debt to equity ratio of 0.63 and a total debt to equity ratio of 0.71 for the quarter ending June 29. Its gross profit as reported stood at $69.65 billion compared to revenue of $287.6 billion.
For the three-month period that ended June 29, UnitedHealth Group Incorporated had $45.8 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $5.07 billion in the quarter, while revenues were grew 15.86%. The analyst consensus anticipated UnitedHealth Group Incorporated’s latest quarter earnings to come in at $5.2 per share, but it turned out to be $5.57, a 7.10% surprise. For the quarter, EBITDA amounted to $7.93 billion. Shareholders own equity worth $935.38 million.
From a technical analysis perspective, let’s take a brief look at UnitedHealth Group Incorporated (UNH) price momentum. RSI 9-day as of the close on 22 September was 40.36%, suggesting the stock is Neutral, with historical volatility in this time frame at 25.39%.
As of today, UNH’s price is $517.62 -1.69% or -$8.80 from its 5-day moving average. UNH is currently trading -5.42% lower than its 20-day SMA and +2.21% higher than its 100-day SMA. However, the stock’s current price level is +1.95% above the SMA50 and +10.22% above the SMA200.
The stochastic %K and %D were 27.04% and 37.51%, respectively, and the average true range (ATR) was 11.60. With the 14-day stochastic at 21.16% and the average true range at 11.23, the RSI (14) stands at 42.32%. The stock has reached -3.39 on the 9-day MACD Oscillator while the 14-day reading was at -5.95.
Loop Capital launched coverage on UnitedHealth Group Incorporated (NYSE: UNH) in its analyst report released on June 17, 2022. The firm assigned the stock a Buy rating. The consensus rating for UnitedHealth Group Incorporated (UNH) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell UNH, while 3 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 21 others rate it as a “buy”.
What is UNH’s price target for the next 12 months?
Analysts predict a range of price targets between $480.00 and $635.00, with a median target of $590.00. Taking a look at these predictions, the average price target given by analysts for UnitedHealth Group Incorporated (UNH) stock is $586.57.